• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病患者发生缺血性心脏病的风险:一项全国性队列研究。

Risk of Ischemic Heart Disease in Chronic Obstructive Pulmonary Disease: A Nationwide Cohort Study.

机构信息

Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.

Research Institute of Clinical Medicine of Jeonbuk National University - Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Korea.

出版信息

J Korean Med Sci. 2023 Oct 30;38(42):e344. doi: 10.3346/jkms.2023.38.e344.

DOI:10.3346/jkms.2023.38.e344
PMID:37904657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10615639/
Abstract

BACKGROUND

Subjects with chronic obstructive pulmonary disease (COPD) have a higher risk of ischemic heart disease (IHD) than individuals without COPD; however, longitudinal evidence is lacking. Therefore, we aimed to estimate the risk of IHD between COPD and control cohorts using a longitudinal nationwide database.

METHODS

We used 2009-2017 data from the Korean National Health Insurance Service National Sample Cohort (NHIS-NSC). Adult participants at least 20 years of age who underwent health examinations and without a history of COPD or IHD were included (n = 540,976). Participants were followed from January 1, 2009, until death, development of IHD, or December 31, 2019, whichever came first.

RESULTS

At baseline, there were 3,421 participants with incident COPD and 537,555 participants without COPD. During a median of 8.0 years (5.3-9.1 years) of follow-up, 2.51% of the participants with COPD (n = 86) and 0.77% of the participants without COPD (n = 4,128) developed IHD, with an incidence of 52.24 and 10.91 per 10,000 person-years, respectively. Participants with COPD had a higher risk of IHD (adjusted hazard ratio, 1.55; 95% confidence interval, 1.25-1.93) than subjects without COPD. Demographics such as age, sex, body mass index, and personal health behaviors including smoking status and physical activity did not show significant interaction with the relationship between COPD and IHD ( for interaction > 0.05 for all).

CONCLUSION

The results indicate that COPD is associated with the development of IHD independent of demographic characteristics and health-related behaviors. Based on these results, clinicians should closely monitor the onset of IHD in subjects with COPD.

摘要

背景

患有慢性阻塞性肺疾病(COPD)的患者发生缺血性心脏病(IHD)的风险高于无 COPD 的个体;然而,目前缺乏纵向证据。因此,我们旨在使用纵向全国性数据库评估 COPD 和对照组之间发生 IHD 的风险。

方法

我们使用了 2009 年至 2017 年来自韩国国民健康保险服务国家样本队列(NHIS-NSC)的数据。纳入至少 20 岁且既往无 COPD 或 IHD 病史的成年参与者(n=540976)。参与者从 2009 年 1 月 1 日开始随访,直至死亡、发生 IHD 或 2019 年 12 月 31 日,以先发生者为准。

结果

在基线时,有 3421 名参与者患有新发 COPD,537555 名参与者无 COPD。在中位数为 8.0 年(5.3-9.1 年)的随访期间,有 2.51%的 COPD 参与者(n=86)和 0.77%的无 COPD 参与者(n=4128)发生了 IHD,发病率分别为 52.24 和 10.91/10000 人年。与无 COPD 者相比,COPD 患者发生 IHD 的风险更高(调整后的危险比,1.55;95%置信区间,1.25-1.93)。年龄、性别、体重指数和个人健康行为(包括吸烟状况和身体活动)等人口统计学因素与 COPD 和 IHD 之间的关系没有显著交互作用(所有交互作用>0.05)。

结论

这些结果表明,COPD 与 IHD 的发生有关,与人口统计学特征和与健康相关的行为无关。基于这些结果,临床医生应密切监测 COPD 患者 IHD 的发病情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9260/10615639/b2d39d065a68/jkms-38-e344-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9260/10615639/538c1c41476b/jkms-38-e344-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9260/10615639/b2d39d065a68/jkms-38-e344-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9260/10615639/538c1c41476b/jkms-38-e344-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9260/10615639/b2d39d065a68/jkms-38-e344-g002.jpg

相似文献

1
Risk of Ischemic Heart Disease in Chronic Obstructive Pulmonary Disease: A Nationwide Cohort Study.慢性阻塞性肺疾病患者发生缺血性心脏病的风险:一项全国性队列研究。
J Korean Med Sci. 2023 Oct 30;38(42):e344. doi: 10.3346/jkms.2023.38.e344.
2
Ischemic heart disease among subjects with and without chronic obstructive pulmonary disease--ECG-findings in a population-based cohort study.患有和未患有慢性阻塞性肺疾病的受试者中的缺血性心脏病——一项基于人群的队列研究中的心电图结果
BMC Pulm Med. 2015 Dec 4;15:156. doi: 10.1186/s12890-015-0149-1.
3
Impact of chronic ischemic heart disease on the health care costs of COPD patients - An analysis of German claims data.慢性缺血性心脏病对慢性阻塞性肺疾病患者医疗费用的影响——基于德国理赔数据的分析
Respir Med. 2016 Sep;118:112-118. doi: 10.1016/j.rmed.2016.08.001. Epub 2016 Aug 2.
4
Decreased Risk of Ischemic Heart Disease in Individuals with Severe Alpha 1-Antitrypsin Deficiency (PiZZ) in Comparison with the General Population.严重的α1-抗胰蛋白酶缺乏症(PiZZ)个体患缺血性心脏病的风险低于普通人群。
Int J Chron Obstruct Pulmon Dis. 2020 Jun 4;15:1245-1252. doi: 10.2147/COPD.S247377. eCollection 2020.
5
COPD prevalence in smokers with stable ischemic heart disease: A cross-sectional study in Tunisia.稳定型缺血性心脏病吸烟者中 COPD 的患病率:突尼斯的一项横断面研究。
Respir Med. 2021 Apr;179:106335. doi: 10.1016/j.rmed.2021.106335. Epub 2021 Feb 16.
6
Tuberculosis and the Risk of Ischemic Heart Disease: A Nationwide Cohort Study.结核病与缺血性心脏病风险:一项全国性队列研究。
Clin Infect Dis. 2023 May 3;76(9):1576-1584. doi: 10.1093/cid/ciac946.
7
Pulmonary Tuberculosis and the Incidence of Lung Cancer among Patients with Chronic Obstructive Pulmonary Disease.肺结核与慢性阻塞性肺疾病患者肺癌发病率的关系。
Ann Am Thorac Soc. 2022 Apr;19(4):640-648. doi: 10.1513/AnnalsATS.202010-1240OC.
8
Influenza vaccination and reduction in risk of ischemic heart disease among chronic obstructive pulmonary elderly.流感疫苗接种与慢性阻塞性肺疾病老年患者缺血性心脏病风险降低
Comput Methods Programs Biomed. 2013 Aug;111(2):507-11. doi: 10.1016/j.cmpb.2013.05.006. Epub 2013 Jun 12.
9
Alcohol and cardio-respiratory deaths in Chinese: a population-based case-control study of 32,462 older Hong Kong adults.中国人群中酒精与心肺疾病死亡情况:一项基于香港32462名老年人的病例对照研究
BMC Public Health. 2009 Feb 5;9:49. doi: 10.1186/1471-2458-9-49.
10
Associations of prior pulmonary tuberculosis with the incident COPD: a prospective cohort study.既往肺结核与 COPD 发病的相关性:一项前瞻性队列研究。
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241239455. doi: 10.1177/17534666241239455.

引用本文的文献

1
Management of COPD With Cardiovascular Risk in Asia: A Review by the Asian Pacific Society of Respirology COPD Assembly.亚洲慢性阻塞性肺疾病合并心血管风险的管理:亚太呼吸学会慢性阻塞性肺疾病大会综述
Respirology. 2025 Sep;30(9):817-830. doi: 10.1111/resp.70103. Epub 2025 Aug 11.
2
Clinical impacts of COVID-19 on severe exacerbation and mortality in interstitial lung disease: prognosis 30 days after infection.新型冠状病毒肺炎对间质性肺疾病严重加重和死亡率的临床影响:感染后30天的预后
Korean J Intern Med. 2025 Jul;40(4):634-644. doi: 10.3904/kjim.2024.388. Epub 2025 Jul 1.
3
The higher serum uric acid to high-density lipoprotein cholesterol ratio is associated with increased risk of chronic obstructive pulmonary disease: result from NHANES 2011-2018.

本文引用的文献

1
Long-Term Outcome of Chronic Obstructive Pulmonary Disease: A Review.慢性阻塞性肺疾病的长期预后:综述
Tuberc Respir Dis (Seoul). 2022 Oct;85(4):289-301. doi: 10.4046/trd.2022.0074. Epub 2022 Jul 13.
2
Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review.慢性阻塞性肺疾病患者合并症的患病率及影响:一项系统评价
Tuberc Respir Dis (Seoul). 2022 Jul;85(3):205-220. doi: 10.4046/trd.2021.0179. Epub 2022 May 27.
3
The Burden of Chronic Obstructive Pulmonary Disease in Cardiovascular Diseases: A Non-Western Perspective.
血清尿酸与高密度脂蛋白胆固醇比值升高与慢性阻塞性肺疾病风险增加相关:来自2011 - 2018年美国国家健康与营养检查调查的结果
BMC Pulm Med. 2025 Jul 4;25(1):322. doi: 10.1186/s12890-025-03743-5.
4
Exacerbation and mortality risk in individuals with bronchiectasis post-COVID-19 recovery.新冠病毒感染康复后支气管扩张症患者的病情加重及死亡风险
ERJ Open Res. 2025 Jun 30;11(3). doi: 10.1183/23120541.00866-2024. eCollection 2025 May.
5
Chronic obstructive pulmonary disease is a risk factor for non-tuberculous mycobacterial pulmonary disease: a population-based matched cohort study.慢性阻塞性肺疾病是非结核分枝杆菌肺病的一个危险因素:一项基于人群的匹配队列研究。
BMJ Open Respir Res. 2025 Jun 20;12(1):e002373. doi: 10.1136/bmjresp-2024-002373.
6
Air Pollution Increases Healthcare Utilization Below Safe Thresholds in Individuals With Asthma.空气污染增加了哮喘患者低于安全阈值的医疗保健利用率。
Allergy Asthma Immunol Res. 2025 May;17(3):349-358. doi: 10.4168/aair.2025.17.3.349.
7
Risk of acute exacerbation of chronic obstructive pulmonary disease after COVID-19 recovery: a nationwide population-based cohort study.新型冠状病毒肺炎康复后慢性阻塞性肺疾病急性加重的风险:一项基于全国人群的队列研究
Respir Res. 2025 Mar 27;26(1):116. doi: 10.1186/s12931-025-03123-x.
8
Impact of physical activity on all-cause mortality in individuals with non-cystic fibrosis bronchiectasis.体育活动对非囊性纤维化支气管扩张症患者全因死亡率的影响。
Front Med (Lausanne). 2025 Feb 26;12:1479638. doi: 10.3389/fmed.2025.1479638. eCollection 2025.
9
Comprehensive risk assessment for pulmonary manifestations in systemic lupus erythematosus: a large-scale Korean population-based longitudinal study.系统性红斑狼疮肺部表现的综合风险评估:一项基于韩国大规模人群的纵向研究。
RMD Open. 2025 Feb 23;11(1):e005267. doi: 10.1136/rmdopen-2024-005267.
10
COVID-19 and risk of long-term mortality in COPD: a nationwide population-based cohort study.2019冠状病毒病与慢性阻塞性肺疾病的长期死亡风险:一项基于全国人群的队列研究
BMJ Open Respir Res. 2025 Feb 17;12(1):e002694. doi: 10.1136/bmjresp-2024-002694.
心血管疾病中慢性阻塞性肺疾病的负担:非西方视角
Tuberc Respir Dis (Seoul). 2021 Apr;84(2):167-170. doi: 10.4046/trd.2020.0151. Epub 2021 Feb 17.
4
Serum Amyloid A in Stable COPD Patients is Associated with the Frequent Exacerbator Phenotype.稳定期 COPD 患者的血清淀粉样蛋白 A 与频繁加重表型相关。
Int J Chron Obstruct Pulmon Dis. 2020 Sep 30;15:2379-2388. doi: 10.2147/COPD.S266844. eCollection 2020.
5
Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.1990-2017 年慢性呼吸道疾病的流行情况和可归因健康负担:2017 年全球疾病负担研究的系统分析。
Lancet Respir Med. 2020 Jun;8(6):585-596. doi: 10.1016/S2213-2600(20)30105-3.
6
Impact of chronic obstructive pulmonary disease on mortality: A large national cohort study.慢性阻塞性肺疾病对死亡率的影响:一项大型全国队列研究。
Respirology. 2020 Jul;25(7):726-734. doi: 10.1111/resp.13678. Epub 2019 Aug 19.
7
Racial differences in comorbidity profile among patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者合并症谱的种族差异。
BMC Med. 2018 Oct 4;16(1):178. doi: 10.1186/s12916-018-1159-7.
8
Cardiovascular comorbidity in patients with chronic obstructive pulmonary disease in the Canary Islands (CCECAN study).加那利群岛慢性阻塞性肺疾病患者的心血管合并症(CCECAN研究)。
Clin Investig Arterioscler. 2017 Jul-Aug;29(4):149-156. doi: 10.1016/j.arteri.2017.01.003. Epub 2017 Apr 5.
9
Inflammatory mechanisms in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的炎症机制。
J Allergy Clin Immunol. 2016 Jul;138(1):16-27. doi: 10.1016/j.jaci.2016.05.011. Epub 2016 May 27.
10
Korean National Health Insurance Database.韩国国民健康保险数据库。
JAMA Intern Med. 2016 Jan;176(1):138. doi: 10.1001/jamainternmed.2015.7110.